$30 Million

Ocata Therapeutics

Follow-on Offering

Bookrunner, June 2015

Provider of cellular therapies and regenerative medicine. The company provides stem cell-based technologies and other proprietary methods in the field of regenerative medicine to bring patient-specific therapies. It also provides regenerative medicine or regenerating human of cells.